Twist Bioscience Corporation Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Twist Bioscience Corporation stock issued during period, shares, employee stock purchase plans for the quarter ending 2021-06-30 was 0.00 shares.
- Twist Bioscience Corporation stock issued during period, shares, employee stock purchase plans for fiscal 2025 was 144.00K shares, a 18.64% decline from fiscal 2024.
- Twist Bioscience Corporation stock issued during period, shares, employee stock purchase plans for fiscal 2024 was 177.00K shares, a 18.43% decline from fiscal 2023.
- Twist Bioscience Corporation stock issued during period, shares, employee stock purchase plans for fiscal 2023 was 217.00K shares, a 123.71% increase from fiscal 2022.
- Twist Bioscience Corporation stock issued during period, shares, employee stock purchase plans for fiscal 2022 was 97.00K shares.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2025-09-30 | 144.00K shares 10-K · filed 2025-11-17 | |
| 2024-09-30 | 177.00K shares 10-K · filed 2024-11-18 | |
| 2023-09-30 | 217.00K shares 10-K · filed 2023-11-21 | |
| 2022-09-30 | 97.00K shares 10-K/A · filed 2023-06-05 | |
| 2021-06-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |